ForecastCONTRACT

Histopathology and antibody screening of Hutchinson Gilford progeria syndrome mouse model DNA editing therapeutic preclinical trial samples.

NATIONAL INSTITUTES OF HEALTHHEALTH AND HUMAN SERVICES, DEPARTMENT OF.NATIONAL INSTITUTES OF HEALTH.NATIONAL INSTITUTES OF HEALTH OLAO

AI Overview

NIH seeks histopathology analysis and antibody screening services for Hutchinson Gilford progeria syndrome mouse model DNA editing therapeutic trial samples. Limited details available.

This summary is AI-generated from the official solicitation.

Key Details

Agency
NATIONAL INSTITUTES OF HEALTH
Funding Amount
Release Date
July 9, 2026
Due Date
July 20, 2026

Official Description

See attached

⚠️ Note: The SAM.gov API does not provide detailed information for this opportunity. Full details may be available in attached documents or by contacting the point of contact directly.

View on official source

Change History

Opportunity AddedJul 9, 2026 at 9:03 PM

Histopathology and antibody screening of Hutchinson Gilford progeria syndrome mouse model DNA editing therapeutic preclinical trial samples.

New SAM.gov opportunity: Histopathology and antibody screening of Hutchinson Gilford progeria syndrome mouse model DNA editing therapeutic preclinical trial samples.

Similar Opportunities

Get Alerts for Opportunities Like This

RallyProp monitors thousands of funding sources and sends instant alerts when opportunities match your technology and capabilities.

Start Free Trial